Effect of emicizumab-neutralizing antibodies on activated partial thromboplastin time-based clotting time test results in patients treated with emicizumab

CONCLUSION: The anti-emi antibodies were shown to completely neutralize emicizumab, making samples pretreated with anti-emi analyzable with the 1-stage assay.PMID:38193066 | PMC:PMC10772886 | DOI:10.1016/j.rpth.2023.102260

Source: Biomed Res - January 9, 2024 Category: Research Authors: Cristina Novembrino Massimo Boscolo-Anzoletti Eleonora Galbiati Sho Shinohara Flora Peyvandi Source Type: research